Carl Sailer - 29 Jun 2021 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role: Director
Signature: /s/ Kostantinos Skordalos, Power of Attorney For: Carl V. Sailer
Issuer symbol: ACXP
Transactions as of: 29 Jun 2021
Net transactions value: +$75,000
Form type: 4
Filing time: 10 Sep 2021, 16:16:31 UTC
Previous filing: 24 Jun 2021
Next filing: 06 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ACXP	Common Stock	Purchase	$75,000	+12,500	+23%	$6.00	67,917	29 Jun 2021	Direct	F1
holding	ACXP	Common Stock						5,000	29 Jun 2021	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock of Acurx Pharmaceuticals, Inc. (the "Issuer") purchased by the reporting person in connection with the Issuer's initial public offering, which closed on June 29, 2021. Due to an unintentional oversight, the transaction reported on this Form 4 was not previously filed on a Form 4 in a timely manner and was omitted from one Form 4 that was subsequently filed. The 12,500 shares of common stock of the Issuer were purchased at the initial public offering price of $6.00 per share.

Content

Represents shares of common stock of Acurx Pharmaceuticals, Inc. (the "Issuer") purchased by the reporting person in connection with the Issuer's initial public offering, which closed on June 29, 2021. Due to an unintentional oversight, the transaction reported on this Form 4 was not previously filed on a Form 4 in a timely manner and was omitted from one Form 4 that was subsequently filed. The 12,500 shares of common stock of the Issuer were purchased at the initial public offering price of $6.00 per share.